Quality Management, Inspections, and the Evolving Landscape for Gene and Cell Therapies

Ensure your organization is prepared for commercial manufacturing and regulatory inspections of its gene and cell therapy products by attending this program for biotech company in-house counsel and regulatory, quality, and compliance personnel.

In this half-day program, hear from members of Arnold & Porter's renowned life sciences practice and highly experienced advanced biologics therapy experts from Lachman Consultants about developing and managing quality for gene and cell therapy products throughout the development process — from filing and licensure to inspectional observations, real-world experiences, and nuances of physical inspections. The program will conclude with an interactive panel discussion on the evolving biologics and gene and cell therapy industry that will also address topics and questions from the audience.